Robust coagulation activation and coagulopathy in mice with experimental acetaminophen-induced liver failure
Journal of Thrombosis and Haemostasis · 2023-09 · 21 (9) · 2430-2440
DOI: 10.1016/j.jtha.2023.03.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023-09. Verfasst von Dafna J Groeneveld und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiology & Diagnostic Investigation, Michigan State University, East Lansing, Michigan, USA. Hauptthemen laut MEDLINE: Liver Failure, Blood Coagulation Disorders, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
BACKGROUND: Patients with acetaminophen (APAP)-induced acute liver failure (ALF) display both hyper- and hypocoagulable changes not necessarily recapitulated by standard hepatotoxic doses of APAP used in mice (eg, 300 mg/kg). OBJECTIVES: We sought to examine coagulation activation in vivo and plasma coagulation potential ex vivo in experimental settings of APAP-induced hepatotoxicity and repair (300-450 mg/kg) and APAP-induced ALF (600 mg/kg) in mice. RESULTS: APAP-induced ALF was associated with increased plasma thrombin-antithrombin complexes, decreased plasma prothrombin, and a dramatic reduction in plasma fibrinogen compared with lower APAP doses. Hepatic fibrin(ogen) deposits increased independent of APAP dose, whereas plasma fibrin(ogen) degradation products markedly increased in mice with experimental ALF. Early pharmacologic anticoagulation (+2 hours after 600 mg/kg APAP) limited coagulation activation and reduced hepatic necrosis. The marked coagulation activation evident in mice with APAP-induced ALF was associated with a coagulopathy detectable ex vivo in plasma. Specifically, prolongation of the prothrombin time and inhibition of tissue factor-initiated clot formation were evident even after restoration of physiological fibrinogen concentrations. Plasma endogenous thrombin potential was similarly reduced at all APAP doses. Interestingly, in the presence of ample fibrinogen, ∼10 times more thrombin was required to clot plasma from mice with APAP-induced ALF compared with plasma from mice with simple hepatotoxicity. CONCLUSION: The results indicate that robust pathologic coagulation cascade activation in vivo and suppressed coagulation ex vivo are evident in mice with APAP-induced ALF. This unique experimental setting may fill an unmet need as a model to uncover mechanistic aspects of the complex coagulopathy of ALF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathobiology & Diagnostic Investigation, Michigan State University, East Lansing, Michigan, USA.
- Department of Pathology and Laboratory Medicine and UNC Blood Research Center, University of North Carolina, Chapel Hill, North Carolina, USA.
- Section of Hepatobiliary Surgery and Liver Transplantation and Surgical Research Laboratory, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- Department of Pathobiology & Diagnostic Investigation, Michigan State University, East Lansing, Michigan, USA; Department of Pharmacology & Toxicology, Michigan State University, East Lansing, Michigan, USA. Electronic…
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
- U.S. Department of Agriculture
- National Institute of Food and Agriculture
- Jet Propulsion Laboratory
- Michigan State University
- University of North Carolina at Chapel Hill
Zitieren
APA
Groeneveld, D. J., Poole, L. G., Bouck, E. G., Schulte, A., Wei, Z., Williams, K. J., Watson, V. E., Lisman, T., Wolberg, A. S., & Luyendyk, J. P. (2023). Robust coagulation activation and coagulopathy in mice with experimental acetaminophen-induced liver failure. Journal of Thrombosis and Haemostasis, 21(9), 2430-2440. https://doi.org/10.1016/j.jtha.2023.03.040
Vancouver
Groeneveld DJ, Poole LG, Bouck EG, Schulte A, Wei Z, Williams KJ, et al. Robust coagulation activation and coagulopathy in mice with experimental acetaminophen-induced liver failure. Journal of Thrombosis and Haemostasis. 2023;21(9):2430-2440. doi:10.1016/j.jtha.2023.03.040
BibTeX
@article{Groeneveld2023,
author = {Groeneveld, Dafna J and Poole, Lauren G and Bouck, Emma G and Schulte, Anthony and Wei, Zimu and Williams, Kurt J and Watson, Victoria E and Lisman, Ton and Wolberg, Alisa S and Luyendyk, James P},
title = {Robust coagulation activation and coagulopathy in mice with experimental acetaminophen-induced liver failure},
journal = {Journal of Thrombosis and Haemostasis},
year = {2023},
volume = {21},
number = {9},
pages = {2430--2440},
doi = {10.1016/j.jtha.2023.03.040}
}
EUVIMED